W, F., L, M., CP, M., CE, B., K, D., H, H., . . . KN, B. (2025). Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase. Blood advances, 9(21), 5598. https://doi.org/10.1182/bloodadvances.2025016898
Chicago Style (17th ed.) CitationW, Fiskus, et al. "Preclinical Efficacy of Tasquinimod-based Combinations in Advanced Myeloproliferative Neoplasms in Blastic Phase." Blood Advances 9, no. 21 (2025): 5598. https://doi.org/10.1182/bloodadvances.2025016898.
MLA (9th ed.) CitationW, Fiskus, et al. "Preclinical Efficacy of Tasquinimod-based Combinations in Advanced Myeloproliferative Neoplasms in Blastic Phase." Blood Advances, vol. 9, no. 21, 2025, p. 5598, https://doi.org/10.1182/bloodadvances.2025016898.
Warning: These citations may not always be 100% accurate.
